webinar instructions - nih common fund · jan 23rd – webinar for x01 applicants. feb 7 01 – x...
TRANSCRIPT
Webinar Instructions• Welcome to the X01 Pre-Application Webinar hosted by the
Gabriella Miller Kids First Pediatric Research Program
• Every participant is muted upon entry. Please remain muted until the question/discussion period. You can unmute yourself by selecting *6 on your telephone or clicking on the mic symbol under “Audio Connection”.
• You can ask technical questions using the chat service to the host throughout the webinar. Please save questions related to the program or the FOA for the question period. Additional program-related questions can be emailed to: [email protected].
This Webinar will be recorded and posted to the Kids First website.
We will start at 3:00 pm (EST) 1
Pre-Application Webinar for Discovery of the Genetic Basis of Childhood Cancers and of
Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01)
January 23rd, 20173:00 pm EST
Introductions:Kids First Leadership Group
Program Officers/StaffLorette Javois (NICHD)Jonathan Kaltman (NHLBI)Adam Felsenfeld (NHGRI)Malcolm Smith (NCI)Jaime Guidry Auvil (NCI)James Coulombe (NICHD) – Sequencing Center Project ScientistMaarten Leerkes (NHLBI) – Data Resource Project Scientist
Common Fund, ODMarie Nierras – ProgramTBD – Policy, Planning, Evaluation, and CommunicationsMichael Steenstra – Operations, and Budget
Admin Point-of-ContactValerie Cotton (NICHD) [email protected]
3
Background• Initiated in response to the 2014 Gabriella Miller Kids First
Research Act– Signed into law on April 3, 2014– Ended taxpayer contribution to presidential nominating conventions– Transferred remaining $126 million into the Pediatric Research
Initiative Fund– Authorized appropriation of $12.6 million per year for 10 years to the
NIH Common Fund for pediatric research; first appropriation was for FY2015
4
Kids First Working Group
• Kids First is a trans-NIH effort supported by the NIH Common Fund
• Institutes that chair the Kids First Working Group: NICHD, NHLBI, NCI, NHGRI
• Other Institutes that are part of the Working Group: NIDCR, NIDA, NIAAA, NIDDK, NIEHS, NEI, NIAMS, NIAID, ORIP, and the CDC
5
Kids First Overall Goal
Develop a data resource, called the “Gabriella Miller Kids First Pediatric Data Resource”, where the pediatric research
community can access well-curated clinical and genetic sequence data that will allow them to
identify genetic pathways that underlie childhood cancer and structural birth defects.
6
Kids First Major Initiatives
1. Cohort identification and DNA sequencing
2. Gabriella Miller Kids First Pediatric Data Resource
3. Data Analyses
7
Kids First Major Initiatives
1. Cohort identification and DNA sequencing• Identify children with childhood cancer and/or structural birth
defects and their families for whole genome sequencing
2. Gabriella Miller Kids First Pediatric Data Resource
3. Data Analysis
8
X01: Third CycleDiscovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01)
1. FY 2015: PAR-15-259• 2 childhood cancer cohorts• 5 structural birth defects cohorts
2. FY 2016: PAR-16-150 • 3 childhood cancer cohorts• 5 structural birth defects cohorts
3. FY 2017: PAR-17-063
9
X01 mechanism• Not an “award”• Recipients are selected for the opportunity to have their
cohort sequenced• No funds, but can apply for R03 to support analysis of
X01 project: PAR-16-348: Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03)
• Not listed in the NIH RePORTER– Abstracts and X01 information listed on Kids First website:
https://commonfund.nih.gov/kidsfirst/fundedresearch
10
PAR-17-063 Goals & Expectations
Visit X01 FAQs: https://commonfund.nih.gov/kidsfirst/faq
11
Sequencing Centers
HudsonAlpha Institute for Biotechnology• Shawn Levy, Ph.D, Director of the
Genomic Services LabSt. Jude Children’s Research Hospital• Jinghui Zhang, Ph.D.• John Easton, Ph.D.
12
Broad Institute of MIT & Harvard• Stacey Gabriel, Ph.D., Senior Director,
Genomics Platform• Michael Talkowski, Ph.D.• Daniel MacArthur, Ph.D.• Gad Getz, Ph.D.
Sequencing Centers
HudsonAlpha Institute for Biotechnology• Shawn Levy, Ph.D, Director of the
Genomic Services LabSt. Jude Children’s Research Hospital• Jinghui Zhang, Ph.D.• John Easton, Ph.D.
Childhood Cancer Cohorts
Broad Institute of MIT & Harvard• Stacey Gabriel, Ph.D., Senior Director,
Genomics Platform• Michael Talkowski, Ph.D.• Daniel MacArthur, Ph.D.• Gad Getz, Ph.D.
Structural Birth Defects Cohorts
13
Sequencing TechnologyPerform sequencing & variant calling (generate BAM/FASTQ & VCF files)
Birth Defects Cohorts– Standard WGS at 30X coverage
Childhood Cancer Cohorts– Germline: Standard WGS at 30X coverage– Tumor (when available): 30X WGS + WES + RNASeq
Possible: linked long read /phased genomes small pilot study currently underway
“Project design will be finalized in discussions among the X01 investigators, the sequencing centers, and NIH program staff"
14
dbGaP Registration & Data Submission
Birth Defects– Register with dbGaP– Phenotype data dbGaP Submission Portal– Sequence data NCBI Sequence Read Archive (SRA)
Childhood Cancers– Register with dbGaP– Biospecimen, Phenotype & Sequence data NCI
Genomic Data Commons (GDC; https://gdc.cancer.gov/)
15
Sequencing
• Goal: Use Whole Genome Sequencing (as well as whole exome, and transcriptome sequencing for tumors) to discover genetic variants contributing to pediatric conditions through germline (and tumor) sequencing
• Expectation: DNA (and RNA for tumor) extractions must be of sufficient quality and concentration for WGS (and WES and RNASeq for tumor)
16
Phenotype Harmonization
• Goal: Facilitate cross-cohort analyses based on common data elements
• Expectations:– Basic data elements are expected, and deep
phenotyping is preferred– For cancer cohorts, NCI’s GDC requires the
submission of specific biospecimen and clinical/phenotype data
• for details, visit: https://docs.gdc.cancer.gov/Data_Dictionary/viewer/
17
Program Balance
• Goal: Broaden the diversity of both pediatric cancer and structural birth defects datasets that are represented in the data resource
• Expectation: Priority may be given to cohorts with conditions not previously sequenced under Kids First (if many applications score well during peer review)
18
Data Sharing• Goal: Make data generated by Kids First as
accessible to the research community as possible• Expectations:
– Cohort participants must have given consent to allow sharing of individual-level sequence and relevant phenotype data through an NIH-approved repository (e.g. dbGaP, SRA, GDC)
– Samples that are consented for broadest level of data sharing are of higher priority (e.g. general research use > disease-specific)
19
Sample Size & Family Structure
• Goal: Sample sizes and family structures are sufficient to lead to genetic discovery
• Expectations: – Large sample size preferred – Minimum of 100 trios; fewer must be scientifically
justified• Consider collaborating with other investigators to pool
samples together – Non-trios: sufficient number of probands and
affected/unaffected family members
20
Analysis Plans
• Goal: Have investigators demonstrate that the proposed project has an adequate research design for genetic discovery, and that the X01 applicants are prepared to perform these analyses
• Expectations:– While Kids First recognizes that analytical power will
increase when the data from each individual study is incorporated with other data that will be part of the Data Resource, it is important to demonstrate that the data will be useable on its own
– Consider partnering with other research teams with relevant expertise to develop the analysis plan
21
Other Attachments
1) Institutional Certification (provisional certification or sample consent form)
2) Sample Information 3) Phenotype Data 4) Family Structure (Optional)
22
fillable form(optional)
Provide an institutional certification, provisional certification, or sample consent form that…
– covers all sites that contribute samples to your project – specifies whether data is consented for deposition in
dbGaP or other NIH-approved repositories– indicates the data use limitations (DULs) and data use
limitation modifiers (see example DULs below)
Use current template: https://gds.nih.gov/Institutional_Certifications.html
23
Other Attachments: Institutional Certifications
Other Attachments: Fillable TableSample Information
24
Phenotype Information & Demographics
25
Other Attachments: Fillable Table
Other Attachments: Pedigree or Table
26
Describe Family structures (proband-parent dyads, proband-parent-sibling quads, multiplex families, consanguineous families)• How many samples per family? How many are affected/unaffected?
Other Application Considerations
You are eligible to apply if:• You have already sequenced a case/proband
and have unsequenced nucleic acids from their parents/siblings/tumor
• You are part of or collaborating with the NIH Intramural Research Program
27
For FY 2017,• Kids First highly encourages all investigators
with a cohort that meets the minimum requirements to consider applying
For FY 2018 (future solicitations),• Kids First encourages research teams to start
collecting samples that meet our requirements now
28
FY17 X01 Timeline
29Fall 2016
December 1st – Published X01 FOA
Spring 2017
Jan 23rd – Webinar for X01 applicants
Feb 7 – X01 Letters of Intent Due
Mar 7 – X01 applications due
April – HG-SEP Review X01 applications
Summer 2017
June-July – Finalize X01 cohort decision & notify recipients
Aug – X01 cohorts enter pipeline
Fall 2017
Thank You!